Xerostomia Therapeutics Market 2027 By Product, Type | The Insight Partners

Xerostomia Therapeutics Market to 2027 - Global Analysis and Forecasts by Product (Salivary Stimulants, Salivary Substitutes, Dentifrices); Type (OTC, Prescription)

Report Code: TIPRE00004316 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION
Xerostomia, also referred to as dry mouth is a condition that results in limited production of saliva or alteration in the saliva quality to keep the mouth wet. Most commonly this is caused during inflammatory autoimmune diseases, nervous-system related diseases including stress, depression, anxiety etc. and traumas.

MARKET DYNAMICS
The Xerostomia Therapeutics Market is anticipated to grow in the forecast period owing to driving factors such as rising prevalence of the associated diseases such as Sjogren's syndrome, increasing usage of prescription medications, rising geriatric population, increasing adoption of chemotherapy and radiotherapy in cancer treatment, and prevalence of diseases such as HIV, Diabetes etc. Nevertheless high cost of Xerostomia therapeutics and lack of awareness is expected to restrict the market growth during the forecast period.

MARKET SCOPE
The "Global Xerostomia Therapeutics Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Xerostomia Therapeutics market with detailed market segmentation by Product, Type, and geography. The global Xerostomia Therapeutics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Xerostomia Therapeutics market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global Xerostomia Therapeutics market is segmented on the basis of Product and Type. Based on Product the market is segmented into Salivary Stimulants, Salivary Substitutes and Dentifrices. Based on Type the market is segmented into OTC and Prescription.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Xerostomia Therapeutics market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Xerostomia Therapeutics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Xerostomia Therapeutics market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Xerostomia Therapeutics market in these regions.

MARKET PLAYERS
The reports cover key developments in the Xerostomia Therapeutics Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Xerostomia Therapeutics Market are anticipated to lucrative growth opportunities in the future with the rising demand for Xerostomia Therapeutics in the global market. Below mentioned is the list of few companies engaged in the Xerostomia Therapeutics market.

The report also includes the profiles of key Xerostomia Therapeutics market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • Acacia Pharma
  • Pfizer, Inc.
  • GlaxoSmithKline plc
  • Church & Dwight Co., Inc.
  • Lupin
  • Sun Pharmaceutical Industries, Ltd.
  • Hikma Pharmaceuticals PLC
  • Pendopharm
  • OraCoat
  • Parnell Pharmaceuticals, Inc.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Xerostomia Therapeutics Market - By Product
1.3.2 Xerostomia Therapeutics Market - By Type
1.3.3 Xerostomia Therapeutics Market - By Region
1.3.3.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. XEROSTOMIA THERAPEUTICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. XEROSTOMIA THERAPEUTICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. XEROSTOMIA THERAPEUTICS MARKET - GLOBAL MARKET ANALYSIS
6.1. XEROSTOMIA THERAPEUTICS - GLOBAL MARKET OVERVIEW
6.2. XEROSTOMIA THERAPEUTICS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. XEROSTOMIA THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. SALIVARY STIMULANTS
7.3.1. Overview
7.3.2. Salivary Stimulants Market Forecast and Analysis
7.4. SALIVARY SUBSTITUTES
7.4.1. Overview
7.4.2. Salivary Substitutes Market Forecast and Analysis
7.5. DENTIFRICES
7.5.1. Overview
7.5.2. Dentifrices Market Forecast and Analysis
8. XEROSTOMIA THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
8.1. OVERVIEW
8.2. TYPE MARKET FORECASTS AND ANALYSIS
8.3. OTC
8.3.1. Overview
8.3.2. OTC Market Forecast and Analysis
8.4. PRESCRIPTION.
8.4.1. Overview
8.4.2. Prescription. Market Forecast and Analysis
9. XEROSTOMIA THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Xerostomia Therapeutics Market Overview
9.1.2 North America Xerostomia Therapeutics Market Forecasts and Analysis
9.1.3 North America Xerostomia Therapeutics Market Forecasts and Analysis - By Product
9.1.4 North America Xerostomia Therapeutics Market Forecasts and Analysis - By Type
9.1.5 North America Xerostomia Therapeutics Market Forecasts and Analysis - By Countries
9.1.5.1 United States Xerostomia Therapeutics Market
9.1.5.1.1 United States Xerostomia Therapeutics Market by Product
9.1.5.1.2 United States Xerostomia Therapeutics Market by Type
9.1.5.2 Canada Xerostomia Therapeutics Market
9.1.5.2.1 Canada Xerostomia Therapeutics Market by Product
9.1.5.2.2 Canada Xerostomia Therapeutics Market by Type
9.1.5.3 Mexico Xerostomia Therapeutics Market
9.1.5.3.1 Mexico Xerostomia Therapeutics Market by Product
9.1.5.3.2 Mexico Xerostomia Therapeutics Market by Type
9.1.5.4 US Xerostomia Therapeutics Market
9.1.5.4.1 US Xerostomia Therapeutics Market by Product
9.1.5.4.2 US Xerostomia Therapeutics Market by Type
9.2. EUROPE
9.2.1 Europe Xerostomia Therapeutics Market Overview
9.2.2 Europe Xerostomia Therapeutics Market Forecasts and Analysis
9.2.3 Europe Xerostomia Therapeutics Market Forecasts and Analysis - By Product
9.2.4 Europe Xerostomia Therapeutics Market Forecasts and Analysis - By Type
9.2.5 Europe Xerostomia Therapeutics Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Xerostomia Therapeutics Market
9.2.5.1.1 Germany Xerostomia Therapeutics Market by Product
9.2.5.1.2 Germany Xerostomia Therapeutics Market by Type
9.2.5.2 France Xerostomia Therapeutics Market
9.2.5.2.1 France Xerostomia Therapeutics Market by Product
9.2.5.2.2 France Xerostomia Therapeutics Market by Type
9.2.5.3 Italy Xerostomia Therapeutics Market
9.2.5.3.1 Italy Xerostomia Therapeutics Market by Product
9.2.5.3.2 Italy Xerostomia Therapeutics Market by Type
9.2.5.4 Spain Xerostomia Therapeutics Market
9.2.5.4.1 Spain Xerostomia Therapeutics Market by Product
9.2.5.4.2 Spain Xerostomia Therapeutics Market by Type
9.2.5.5 United Kingdom Xerostomia Therapeutics Market
9.2.5.5.1 United Kingdom Xerostomia Therapeutics Market by Product
9.2.5.5.2 United Kingdom Xerostomia Therapeutics Market by Type
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Xerostomia Therapeutics Market Overview
9.3.2 Asia-Pacific Xerostomia Therapeutics Market Forecasts and Analysis
9.3.3 Asia-Pacific Xerostomia Therapeutics Market Forecasts and Analysis - By Product
9.3.4 Asia-Pacific Xerostomia Therapeutics Market Forecasts and Analysis - By Type
9.3.5 Asia-Pacific Xerostomia Therapeutics Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Xerostomia Therapeutics Market
9.3.5.1.1 Australia Xerostomia Therapeutics Market by Product
9.3.5.1.2 Australia Xerostomia Therapeutics Market by Type
9.3.5.2 China Xerostomia Therapeutics Market
9.3.5.2.1 China Xerostomia Therapeutics Market by Product
9.3.5.2.2 China Xerostomia Therapeutics Market by Type
9.3.5.3 India Xerostomia Therapeutics Market
9.3.5.3.1 India Xerostomia Therapeutics Market by Product
9.3.5.3.2 India Xerostomia Therapeutics Market by Type
9.3.5.4 Japan Xerostomia Therapeutics Market
9.3.5.4.1 Japan Xerostomia Therapeutics Market by Product
9.3.5.4.2 Japan Xerostomia Therapeutics Market by Type
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Xerostomia Therapeutics Market Overview
9.4.2 Middle East and Africa Xerostomia Therapeutics Market Forecasts and Analysis
9.4.3 Middle East and Africa Xerostomia Therapeutics Market Forecasts and Analysis - By Product
9.4.4 Middle East and Africa Xerostomia Therapeutics Market Forecasts and Analysis - By Type
9.4.5 Middle East and Africa Xerostomia Therapeutics Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Xerostomia Therapeutics Market
9.4.5.1.1 South Africa Xerostomia Therapeutics Market by Product
9.4.5.1.2 South Africa Xerostomia Therapeutics Market by Type
9.4.5.2 Saudi Arabia Xerostomia Therapeutics Market
9.4.5.2.1 Saudi Arabia Xerostomia Therapeutics Market by Product
9.4.5.2.2 Saudi Arabia Xerostomia Therapeutics Market by Type
9.4.5.3 U.A.E Xerostomia Therapeutics Market
9.4.5.3.1 U.A.E Xerostomia Therapeutics Market by Product
9.4.5.3.2 U.A.E Xerostomia Therapeutics Market by Type
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Xerostomia Therapeutics Market Overview
9.5.2 South and Central America Xerostomia Therapeutics Market Forecasts and Analysis
9.5.3 South and Central America Xerostomia Therapeutics Market Forecasts and Analysis - By Product
9.5.4 South and Central America Xerostomia Therapeutics Market Forecasts and Analysis - By Type
9.5.5 South and Central America Xerostomia Therapeutics Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Xerostomia Therapeutics Market
9.5.5.1.1 Brazil Xerostomia Therapeutics Market by Product
9.5.5.1.2 Brazil Xerostomia Therapeutics Market by Type
9.5.5.2 Argentina Xerostomia Therapeutics Market
9.5.5.2.1 Argentina Xerostomia Therapeutics Market by Product
9.5.5.2.2 Argentina Xerostomia Therapeutics Market by Type
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. XEROSTOMIA THERAPEUTICS MARKET, KEY COMPANY PROFILES
11.1. ACACIA PHARMA
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. PFIZER, INC
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. GLAXOSMITHKLINE PLC
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. CHURCH AND DWIGHT CO., INC
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. LUPIN
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. SUN PHARMACEUTICAL INDUSTRIES, LTD
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. HIKMA PHARMACEUTICALS PLC
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. PENDOPHARM
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. ORACOAT
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. PARNELL PHARMACEUTICALS, INC.
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

- Acacia Pharma
- Pfizer, Inc.
- GlaxoSmithKline plc
- Church & Dwight Co. , Inc.
- Lupin
- Sun Pharmaceutical Industries, Ltd.
- Hikma Pharmaceuticals PLC
- Pendopharm
- OraCoat
- Parnell Pharmaceuticals, Inc.